You are here

News

subscribe

The latest international news, analysis and features on the HIV epidemic from AVERT. Share your views and expertise with your peers in the comments box below the articles.

03 August 2017

Injectable antiretroviral drugs – a ‘remarkable milestone’

Long-lasting antiretroviral drugs injected monthly present a ‘remarkable milestone’ in treatment options for people living with HIV

0
20 July 2017

HIV drug resistance is rising and needs urgent attention, says World Health Organization

Without urgent action, HIV drug resistance is set to derail the HIV response and presents a significant threat to public health, the World Health Organization (WHO) warns today.

0
22 June 2017

PrEP now included on the WHO Essential Medicines List

Key HIV drugs added to the list of medicines critical to public health, including tenofovir for HIV prevention, and dolutegravir.

0
21 February 2017

Pre-treatment drug resistance as high as 17% with no impact on viral load suppression

‘Surprising’ research from Conference on Retroviruses and Opportunistic Infections (CROI) shows drug resistance does not impact test-and-treat roll-out in South Africa – at least in the short term.

0
06 January 2017

HIV drug resistance: a new threat for low- and middle-income countries

With 17 million people now accessing antiretroviral treatment worldwide, HIV drug resistance has the potential to unravel progress towards the Fast-Track target of ending AIDS by 2030.

0
24 November 2016

Capsule which delivers medicine for weeks after swallowing could revolutionise HIV treatment

A new pill technology has the potential to simplify HIV treatment and curb the rise of drug-resistant HIV.

0
21 March 2016

ART has averted over 850,000 HIV-related opportunistic infections in low and middle income countries

Rollout of antiretroviral therapy (ART) in low and middle income countries has averted over 850,000 cases of HIV-related opportunistic infections at a saving of at least $47 million per year.

0
05 February 2016

Analysis: Tenofovir resistance ‘surprisingly common’

Resistance to the commonly prescribed antiretroviral drug tenofovir is ‘surprisingly common’, according to findings published in the Lancet Infectious Diseases last week. 

0
30 September 2015

New WHO guidelines recommending HIV treatment for all

World Health Organisation releases new guidelines recommending all people living with HIV receive antiretroviral treatment, regardless of CD4 count.

0
28 May 2015

Major treatment trial concludes time is of the essence

A large international trial has overwhelmingly concluded that the health of people living with HIV considerably benefits from starting treatment early. It is widely acknowledged that giving antiretrovirals (ARVs) to HIV positive people before their CD4 count – a measure of the immune system – drops too low, makes treatment more effective. This study provides crucial new evidence that could be a game-changer in the delivery of HIV treatment around the world.

0